Prescribed List Reforms - Consultation Paper 8b - Alignment of amount charged for supply of a device with corresponding PL benefit
Overview
In July-August 2023, the department consulted on several proposed measures related to compliance, assurance, and information sharing as part of the reforms to the Prescribed List (Consultation Paper 7). Among the measures, was the proposal to align the amount charged for the supply of a medical device or human tissue product with the corresponding PL benefit.
Stakeholders raised concerns and questions around the proposed measure. As a result, we are undertaking additional consultation to refine and finalise this proposed measure.
Why your views matter
We are in the ‘discovery’ phase for this measure and want to work collaboratively with stakeholders to create a fit-for-purpose compliance measure and reduce the risk of unintended consequences.
We ask that stakeholders provide feedback on the proposed measures. Please read Consultation Paper 8b, consider the questions, and provide your responses, and any other comments about the matters raised in this consultation paper.
Audiences
- Non-government organisations
- State government agencies
- Commonwealth agencies
- Local governments
- Health professionals
- Health workforce
- Medical Devices & IVDs
Interests
- Hospitals
- Health technology
- Legislation
- Pharmaceutical benefits
- Health insurance
- Strategic Policy
- Policy Development
Share
Share on Twitter Share on Facebook